Directed the largest and first deployment of KP HealthConnect, Kaiser-Permanente’s revolutionary program to improve the quality and safety of healthcare through the use of information technology. This program supports the largest region of Kaiser Permanente with over 3 million lives and has been used by over 7,000 physicians in 13 hospitals and 140 clinics. His team of world class project managers completed the project more than a year ahead of schedule and nearly $260 million under budget. Kaiser Permanente has been recognized as the national leader for both outpatient and inpatient systems, leading the country for hospitals awarded with the top HIMSS level 7 designation, and receiving the prestigious Davies Award in 2012. His team has hosted dozens of international delegations who have studied this program, and John has consulted internationally on numerous Health IT issues.Read full bio →
David Sayen assumed the position of Regional Administrator of the Centers for Medicare & Medicaid Services, Region IX in February 2008. David is based in San Francisco, and his jurisdiction includes California, Arizona, Nevada, Hawaii, and the Pacific Territories. He replaces Acting Regional Administrator Charlotte Yeh, who is returning to her regular duties as Regional Administrator of the New England region of CMS.Read full bio →
Steve Myers has 17 years of experience providing direct information technology (IT) solutions to public sector behavioral health and medical programs in multiple states, including the country's largest public behavioral health contract in Maricopa County, Arizona. His primary focus is on behavioral health IT, business operations and implementations. His prior experience includes additional consulting work in the design of IT and business systems in the public sector environment and the US government.Read full bio →
Paul Markovich is President and CEO of Blue Shield of California, a three million member not-for-profit health plan serving the state's commercial, individual and government markets. Markovich assumed the position on January 1, 2013.
As President and CEO, Markovich drives Blue Shield's mission to ensure Californians' access to high-quality health care at an affordable price. A 16-year Blue Shield veteran, Markovich previously served as COO, in which capacity he oversaw health care services, network management, e-business, marketing, product development, customer operations and Blue Shield's three business units offering medical and specialty benefits coverage.
Dr. Michael Blum is the Associate Vice Chancellor for Informatics and a Professor of Medicine in Cardiology at UCSF. As an active clinician, Dr. Blum is passionate about wellness and prevention of heart disease through lifestyle.
Prior to his medical career, Dr. Blum was trained as an engineer, and he applies his expertise in technology to health care as UCSF’s Chief Medical Information Officer and Director of the Center for Digital Health Innovation at UCSF which develops and evaluates novel applications, devices, and platforms in pursuit of Precision Medicine. He led the successful $165M enterprise deployment of Epic’s electronic health record at UCSF and the development of a large scale research data repository.Read full bio →
Anne has 25 years investing and mentoring experience with MedStars, and has been a pioneer entrepreneur and investor in the emerging HealthTech sector. Companies in which Anne has been involved have been market changers and have grown to $6 billion market cap. She has startup operating experience as CEO and VP as well as public and private board positions. Anne earned a Master in Business Engineering, Brussels and an MBA, Harvard.
Amir Dan Rubin serves as President and CEO of Stanford Health Care in Palo Alto, California. Stanford Health Care seeks to serve humanity through science and compassion, one patient at a time, through its commitment to care, educate, and discover. As a part of Stanford University, the medical center has made groundbreaking impacts in medical innovation, garnering five Nobel prizes to date. Stanford seeks to deliver leading edge and highly coordinated care, and is recognized as a national leader in quality and safety. Stanford is also amongst the nation's most advanced adopters of information technology, and is currently undergoing a major modernization project to develop new state-of-the-art facilities.Read full bio →
Chris Willrich is Regional Vice President Strategy & Business Development with Sutter Health. In this role he oversees physician, service line and capital planning, as well as directing in-region joint venture and merger and acquisition activity.
Prior to his eight years with Sutter, Chris spent four years as a Principal with MedBridge Development, which focuses on syndicating physician investment in surgery centers, medical office buildings and ancillary services. Chris began his career doing strategic planning and partnership development work in the high technology sector. He received his BA from Yale University and his MBA from the Kellogg Graduate School of Management at Northwestern University. He lives in the Oakland hills with his wife and two children.
Seth oversees Evolent Health’s client transformation practice. He most recently served as the Chief Transformation Officer for the Geisinger Health System prior to joining Evolent. His responsibilities included providing business leadership to large-scale innovation projects within the health system (e.g., Geisinger Accelerated Performance Program) and external consulting for Geisinger Ventures. Prior to Geisinger, Seth was Senior Vice President, Strategic Services for The Children’s Hospital of Philadelphia (CHOP). Seth led CHOP’s proton therapy development initiative, national contracting for tertiary services and strategic plan development and management. Before assuming the strategic services role, Seth had executive responsibilities for CHOP-affiliated Children’s Health Net, a pediatric managed care organization that developed and managed a globally capitated 100+ PCP network under contract with the dominant regional HMO. Seth came to CHOP after a 9-year consulting career with a large national health care firm. His practice areas included clinical resource management, managed care, service line strategy, hospital redesign and strategy.
Dr. Wen Dombrowski, MD, MBA is the Chief Medical Information Officer and Vice President of Connected Health for the VNA Health Group, a provider of homecare and community health. In her current role, she oversees the teams working on new business models, care coordination, population health, telehealth, analytics, I.T. & social media. Her teams partner with hospitals, ACO’s, payors, tech companies, and other stakeholders to deliver new care models.Read full bio →
As co-founder and CEO of Grand Rounds, Owen believes that patients will achieve better healthcare outcomes through the intersection of technology, medical expertise, and extraordinary patient care. Prior to Grand Rounds, Owen co-founded Reputation.com and grew the company into the worldwide leader in online reputation and privacy management; he also held executive positions at eBay and Accenture (Health and Life Sciences Practice). Owen received a BA with honors from Trinity College and received an MBA from Stanford Graduate School of Business. He was recently named an “Innovator” in the Institute for Healthcare Consumerism’s 2013 Superstar Awards
Bryan Roberts, Ph.D. joined Venrock as a Kauffman Fellow in 1997. He is based in Venrock's Palo Alto office and focuses on a broad range of healthcare investments. Bryan is currently Chairman of the Board of Directors of Achaogen, Castlight Health, and Ironwood Pharmaceuticals (NASDAQ: IRWD) and also serves on the Board of several other companies, including Ariosa Diagnostics, Doctor on Demand, Grand Rounds, Intarcia, Kyruus, and Zeltiq (NASDAQ: ZLTQ). Past investments include athenahealth (NASDAQ: ATHN), CodeRyte (acquired by 3M), Ikaria (acquired by Madison Dearborn) Illumina (NASDAQ: ILMN), Sirna Therapeutics (acquired by Merck) and Xenoport (NASDAQ: XNPT). Bryan was named a Henry Crown Fellow by the Aspen Institute in 2006 and has been the highest-ranking healthcare investor on Forbes’ Midas List since 2008.Read full bio →
Jeff Tangney started Epocrates from his Stanford dorm room in 1999 and led its growth over a decade to IPO. In 2010, he started Doximity with the goal of building a free, secure medical network. It has since grown to over 40% of US physicians as active, verified members. Previously, Jeff worked at Goldman Sachs and ZS Associates. He was named E&Y Entrepreneur of the Year Northern California in 2005 and PharmaVoice Top 100 Most Inspiring in 2006.
Dr. Peter Hudson is a physician and entrepreneur with more than 20 years of experience founding and growing healthcare-related businesses.
In 2008, Hudson co-founded iTriage, now a subsidiary of Aetna, along with Dr. Wayne Guerra. Dr. Hudson continues to advise on the strategic vision for the consumer healthcare technology that empowers individuals to make better healthcare decisions. The iTriage exit was considered the first significant exit in the mobile health space and has fast become the leading personal healthcare technology with more than 11 million downloads.
Jeff Arnold is Chairman and CEO of Sharecare, a health and wellness engagement platform he founded with Dr. Oz, in partnership with Harpo Productions, Sony Pictures Television and Discovery Communications. Sharecare helps people maximize their human potential by connecting them to personalized health resources including high-quality information from experts, clinical decision support tools, interactive programs and local healthcare providers.Read full bio →
Board Certified Physician, Dr. Pat Basu, is the Chief Medical Officer of Doctor on Demand. He was previously the Chief Operating Officer, Chief Medical Officer, and Director on the Board at vRad – the largest technology enabled national radiology practice. Dr. Basu also served on the State Board of Health in Illinois.
Dr. Basu helped shape economic and health care agendas during his time as a White House Fellow, and has also held faculty and research appointments at Stanford University that centered on health care cost, access and quality. Throughout his career he has consulted for Fortune 500 companies, venture capital firms, and major medical centers on growth strategy, cost containment, revenue enhancement, and operational optimization. Dr. Basu holds a Medical Doctorate and Masters in Business Administration from University of Chicago. He holds a degree in Mechanical Engineering from University of Illinois.
Jody Holtzman has more than two decades of experience helping companies develop and implement competitive strategies and achieve their strategic market goals. At AARP, he leads the Thought Leadership group, where his focus is to stimulate innovation and entrepreneurship in the market that benefits people over 50. This involves areas such as health innovation, the future of technology and the 50+, technology design for all, and 50+ entrepreneurship. It also involves developing partnerships with non-traditional players for AARP, such as the venture capital community, and the consumer electronics and technology industries. Previously, Jody led AARP’s Research and Strategic Analysis group.Read full bio →
Barb Johnston, CEO and Co-Founder of HealthLinkNow, Inc. has extensive expertise as an executive in the business, legal and policy aspects of the Telemedicine industry. Ms. Johnston is the Project Director of the Patient-Centered Medical Home/Mental Health program funded with $7.7 million from the CMS Innovation Initiative 2012-2015.Read full bio →
Mike is a commercial leader who has worked with companies in almost every sector of health care. He believes that small companies with new ideas can change healthcare, but only if they work hand-in-hand with current leaders in the healthcare world. He is committed to making Omada into the leader of a new generation of health providers focused on evidence-based digital health programs for specific, complex diseases. Mike joined Omada from biotechnology leader Gilead Sciences, where he spent 6 years as Senior Director of Commercial Strategy, with experience in new product development, M&A, and marketing. Mike was previously with the healthcare practice at McKinsey & Company where he worked with healthcare clients in biotechnology/pharma, medical devices, health systems, and global health. Mike has an MBA from Stanford Business School as well as an MSc in Health Services Research from Stanford Medical School.
Joel Krikston is a Managing Director with Merck’s Global Health Innovation Fund, LLC (“GHI”). Joel is focused on identifying new investment opportunities in Health Information Technology and Technology Enabled Solutions with an emphasis on Decision Support, Accountable Care and Population Health. Joel is currently on the Board of MedCPU, Inc., is a Board Observer at Electrocore, LLC and is GHI’s representative to the New York Digital Health Accelerator.Read full bio →
Healthcare investor Wende Hutton brings 20 years of experience to identifying, investing in and building companies that are changing the practice of medicine. She has facilitated bringing over a dozen medical devices and drugs to market, and currently sits on the boards of Aldea Pharmaceuticals, Butterfly Health, Chimerix (CMRX), Dermira, Labrys Biologics, ReVision Optics, Theraclone Sciences and Transcend Medical.Read full bio →
With over 30 years of experience, Casper is a veteran of the medical device and life sciences industry. He brings extensive operating knowledge to Norwest Venture Partners having led marketing and commercialization efforts for cardiovascular device, specialty pharmaceutical, and diagnostic companies. Casper focuses on mid-to-late-stage investments in medical devices, specialty pharmaceuticals, healthcare services, and healthcare IT. Along with his current board seats at Intersect ENT, iRhythm Technologies, and Simpirica Spine, Casper has invested in Misfit Wearables. He was previously on the board of Basis (acquired by Intel).
As a physician, Jon Root evaluates investments in the medical field with a practitioner's eye. A common investment criteria when evaluating business opportunities in the biotechnology or medical devices fields is: does this solution meet, or begin to address, an unmet clinical need? Jon goes beyond that: is the innovation easily usable?
"The greatest idea in the world will not be successful if it's not practical to use," says Jon. Jon spent nine years in clinical practice before joining USVP in 1995 as a Ewing Marion Kauffman Fellow in venture capital. He became a general partner in 1997. Before USVP, Jon was on the faculty and clinical staff at The New York Hospital-Cornell Medical Center in New York City. There he was an Assistant Professor of Neurology and Director of the Neurology-Neurosurgery Intensive Care Unit. He is board certified in neurology.
Anthony is a seasoned healthcare executive with over 15 years of industry experience. In his current role as CMO with Cognizant he is helping to drive various aspects including care delivery and risk management. As a successful entrepreneur, he has experience in creating and managing start-up companies. His accomplishments in the healthcare industry recently lead to his recognition as Dorland Health’s 2010 Medical Director of the Year. In his previous role as Senior Vice President and Medical Director for WellPoint, he was responsible for all aspects of care delivery (utilization management, case management, wellness, and condition care) for 34 million members.Read full bio →
Kent is the Chief Medical Officer for Safeway, Inc., a fortune 100 company with over 150,000 employees and is responsible for supporting the company's portfolio of health care programs including its employee and consumer wellness and prevention activities. He is the President of Safeway Health, a subsidiary of Safeway Inc. that provides solutions that engage employees to become active health consumers that results in improved health and reduced cost.Read full bio →
Dr. Gunn oversees a software and services business unit with more than 100 employees who are dedicated to aggregating, standardizing and analyzing more than 100 million patient encounters a year. Valence’s Population Health solutions help clients better manage clinical risk and improve quality across the care continuum by using real-time, clinical data to drive relevant and credible provider-oriented analytics. Prior to joining Valence, Dr. Gunn served as Chief Operating Officer of Verisk Health, where he was responsible for Verisk Health's unified business operations. Prior to that, Dr. Gunn served as Senior Vice President of Clinical Solutions at D2Hawkeye until its acquisition by Verisk. Dr. Gunn joined D2Hawkeye from McKinsey Company’s healthcare practice, where he served as a management consultant. Dr. Gunn completed his residency in Internal Medicine at the University of California in San Francisco and received his BA in Molecular Biology from UC Berkeley.
A serial entrepreneur, John has founded and held senior management positions in several startup companies. For eight years, John was the president and CEO of MedHelp, the world's largest health community, which was recently acquired by Physicians Interactive. John co-founded Flash Communications, a startup company that developed real-time two-way messaging systems acquired by Microsoft.
John was Co-Founder and Director of Smartleaf, a financial software company that provided account management solutions, and later, Vice President of Business Development and Marketing at DESoFT, a startup company acquired by Merrill Lynch that developed online real-time brokerage systems for retail brokerage firms. John started his career in healthcare performing research on guidance systems for robotic surgery at IBM T. J. Watson Research Center. Additionally, he was the head of the Technology Practice in Goldman Sachs' Private Equity Group investing in healthcare and technology. John received a B.S. and M.S. in Computer Science and Electrical Engineering from the MIT and an MBA from College des Ingenieurs in France.
With twenty years of experience in medical technology, Dr Alan Stein brings both breadth and depth of knowledge, bridging the gap between medical, technical and business experience.
Dr Stein holds a Medical Doctorate and a Doctor of Philosophy in biophysics and molecular biology from the University of Pennsylvania. After training in internal medicine at the Hospital of the University of Pennsylvania, Dr Stein pursued his passion for advancing medical technologies, through innovation and commercialization.
Lisa Suennen is Managing Partner at Venture Valkyrie Consulting, LLC, a consulting firm providing advisory services to companies, organizations and private equity firms in the healthcare field. Additionally, Lisa is a Senior Advisor to Psilos Group, a healthcare-focused venture capital and growth equity firm that focuses on the healthcare information technology, healthcare services and medical device sectors. Lisa was a co-founder of Psilos Group and a Partner at the firm from 1998-2014.
Prior to Psilos, Lisa was at Merit Behavioral Care (formerly American Biodyne, Inc), an $800mm behavioral healthcare company where she held various senior executive roles from its early start-up days through exit. Previously, Lisa held various positions in marketing and product management in companies in the high technology field.
Bryce Williams is Managing Director of Towers Watson’s Exchange Solutions business segment. Towers Watson is a global leader in HR consulting services and operates the U.S.’s largest private Medicare exchange as well as exchanges for all workforce populations, including part-time and full-time employees. Mr. Williams was Ernst & Young’s Entrepreneur of The Year in Business Services for Northern California. He served as senior vice president of marketing and business development for eHealth, Inc. before founding Extend Health, which was ranked no. 94 on Inc. magazine’s 2010 Inc. 500 list of the fastest-growing companies. Towers Watson acquired Extend Health in 2012.
Dr. Rideout is currently Senior Medical Advisor for Covered California, the Health Insurance Exchange for the State of California. In this role Dr. Rideout oversees all clinical quality, network management and delivery system reform objectives for Covered California as outlined in its model contract with partner health plans and their physician and hospital partners.
Previously Dr. Rideout was SVP, Chief Medical Officer for The TriZetto Group and also served as the Chief Medical Officer and global leader of the healthcare division for Cisco Systems Internet Business Solutions Group. While at Cisco, Dr. Rideout also served as a member of the American Health Information Community (AHIC’s) Chronic Care Workgroup for the US Department of Health and Human Services. Prior to Cisco, Dr. Rideout was Chief Medical Officer and SVP for Blue Shield of California and head of Quality Management for Blue Cross of California/WellPoint.
October 14, 2014
Gale Richards has built and developed senior leadership teams for fast-growing Healthcare Technology companies for over 25 years. As both a seasoned executive recruiter and a hands-on sales and marketing leader in the healthcare space, Gale knows what it takes to understand a company’s DNA and build the right teams to accomplish its mission.
As a partner at BioQuest since 2003, Gale has become an essential advisor to CEOs, board members and venture capitalists as they search for exactly the right talent for their senior leadership teams. Gale’s search experience is international and includes C-suite, board members and senior executives for every cross-functional role. Gale’s sectors of expertise include: Digital Health, Medical Devices and Diagnostics.
James M. Sweeney has founded ten health care product and service companies including Caremark, Coram, Bridge Medical and CardioNet. None of the ten have failed. Caremark was sold to CVS in 2007 for $24 billion and they recently announced the purchase of Coram for $2.1 billion. CardioNet reached nearly $1 billion value shortly after their IPO in 2008.
Jim has successfully taken four companies public, led an LBO resulting in a 650% return to investors in less than four years, raised over $2 billion in financing for his various companies including $500 million in venture capital, $700 million in debt financing, $400 million in four IPO’s – and sold two companies for over $1 billion.
Dave Thornton oversees the recruitment, development and engagement of all Evolent Health employees. Dave is responsible for establishing the company's talent foundation and building programs that foster and grow the Evolent culture. Prior to joining Evolent, Dave held a variety of HR executive positions at AOL, Inc. including both line HR and Center of Excellence roles, most recently as the company's VP of Talent Management. Dave began his career working with Fortune 500 clients as an organizational development consultant at HumanR, Inc. He received his Master's degree in industrial-organizational psychology from George Mason University.
Margaret Laws is director of the Innovations for the Underserved program at the California HealthCare Foundation. In this role she oversees the Foundation’s work to reduce barriers to efficient, affordable care for the underserved. She also created and manages the CHCF Health Innovation Fund, a mission-focused fund investing in companies that improve access to and reduce cost of health care.Read full bio →
Marty Felsenthal has spent his career working with emerging growth health care services and health care information technology companies, initially as an investment banker at Alex. Brown & Sons, where he worked closely with Ed Cahill and Russ Ray, and, since 1997, as a venture investor focused on health care services and health care information technology companies.Read full bio →
Cora serves as company President & CEO of Sterling HSA, a company she founded in 2004. Cora has 25 years of management experience in health care finance and delivery. Prior to founding Sterling HSA, Cora was President of the Health Plans division of Health Net, Inc., an insurance provider that operated in seven states and achieved revenue of $8 billion from health plans. She has also served as President of Prudential's western health care operations, CEO of Blue Shield of California, Bay Region and Regional Manager for Kaiser Permanente of Hawaii.Read full bio →
Mike Bates is Co-Head of the Life Science Screening Committee at the Band of Angels and an active member of the Life Science Angels. He has invested in over 30 startups, about two-thirds of which are medical technology related. His portfolio includes companies such as Practice Fusion, HealthCrowd, CogENT Therapeutics, and Aerin Medical.
He formerly served as a Director of Catheter Connections, Inc. and as a Director and Audit Committee Chairman of BÂRRX Medical, Emphasys Medical, and Satiety.
Michael Esquivel focuses his practice on strategic counseling to emerging and high-growth companies primarily in the digital/mobile health, Internet, social networking, information technology and clean technologies industries in all aspects of general corporate and corporate securities law—from formation and corporate governance responsibilities to equity incentives and employment issues to intellectual property and commercial transactions. He has negotiated and structured a wide variety of corporate transactions including: seed and venture capital financings, initial public offerings, mergers and acquisitions, corporate reorganizations and debt financings. In addition, Michael has represented and advised venture capitalists and investment banks.Read full bio →
Nina Kjellson has been investing in health care at InterWest since 2002 and has been a Managing Director at the firm since 2008. Current investments include Alvine Pharmaceuticals, Alt12, Cebix, Eiger Biopharmaceuticals, Labrys Biologics, Lycera, Ocera (OCRX), PrimeraDx, and WellTok. Nina also co-sponsored InterWest's investment in TESARO (TSRO). Previous investments include Aspreva (ASPV; acquired by Galenica), NovaCardia (acquired by Merck,) CNS Therapeutics (acquired by Covidien) and Trius Therapeutics (TSRX; acquired by Cubist).Read full bio →
Laureen joined FLG in 2011 and presently serves on the Firm’s Management Committee. Laureen has over 30 years of senior management experience as President and CEO, COO, CFO and General Counsel of various private and public life sciences, medical technology, consumer products and technology companies. Additionally, she has served as a member of the Board of Directors of both public and private companies, and has chaired their respective Audit Committees.Read full bio →
Over the last 25 years, Mark has provided creative financing solutions to hundreds of companies across the country. As Senior Vice President of the Specialty Finance division at Square 1 Bank, Mark provides creative, non-dilutive and streamlined accounts receivable - based credit solutions for technology and life science companies. He focuses on entrepreneur-backed, angel or venture-backed companies with a need for capital without additional dilution. Prior to Square 1 Bank, Mark was co-founder and President of Sand Hill Finance, a private finance company focused on emerging growth technology companies, which was acquired by Square 1 Bank in 2013. Mark has held senior positions at Imperial Bank of California, Sand Hill Capital and Silicon Valley Bank.
Aftab has over 17 years of experience in public accounting. He has substantial experience in serving medical device, life sciences and technology sectors. Aftab has served public and private companies ranging from start-up, development stage enterprises to established multinational companies.
Aftab has significant experience with SEC reporting, mergers and acquisitions, international operations and strategic partnerships. He has participated in the preparation of numerous IPOs and secondary public equity and debt registration statement filings as well as on-going Securities and Exchange Commission reporting.
Michael O'Donnell is a partner in the Palo Alto office of Morrison & Foerster LLP, specializing in corporate and securities law. He has more than 30 years of experience providing general corporate representation to biopharmaceutical and other life sciences companies. He offers particular expertise in venture capital financings, public offerings, mergers and acquisitions, strategic alliances, technology licensing, and corporate spin-out transactions. He represents numerous public and private biopharmaceutical, medical device, diagnostic, and instrumentation companies.
Tom Duley, a partner in King & Spalding’s Silicon Valley Corporate Practice Group, concentrates his practice on technology transactions for life sciences clients. Mr. Duley negotiates, drafts and manages intellectual property and commercial transactions for life sciences companies, including collaboration agreements between biotechnology and pharmaceutical companies, licensing agreements with commercial businesses and academic institutions, supply and manufacturing agreements, distribution agreements and asset purchases and sales involving drug products and manufacturing facilities.Read full bio →
Dean Hovey, a native of Silicon Valley, joined Digifit, Inc. as its president and CEO in the fall of 2011. Digifit combines mobile personal technology with experience design to help people form lifelong healthy habits.
Over the past 30 years Dean helped start 12 technology based companies. He has held senior executive team positions in two public companies. His personal experience spans retail, product design, entrepreneurship, business development, general management and venture capital.